Clinical Trials
3 trialsNCT01507168 2020-04-03
A Study of GC33 (RO5137382) in Patients With Advanced or Metastatic Hepatocellular Carcinoma
Hoffmann-La Roche
Phase 2 Completed
NCT00976170 2014-10-03
Study of GC33 and Sorafenib in Combination in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)
Chugai Pharmaceutical
Phase 1 Completed
NCT00746317 2012-10-17
A Phase I Study of GC33 in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)
Chugai Pharmaceutical
Phase 1 Completed